The Economic Burden of Cardiovascular Disease in the United States

Cardiovascular disease (CVD) is the leading cause of death in the United States and a major driver of healthcare spending. Combined direct costs, such as hospitalizations, procedures, and medications, with indirect costs from lost productivity and caregiving, exceed $500 billion each year and are expected to surpass $1 trillion by 2035. Wide cost variation across health systems underscores inefficiencies and inequities. Women, older adults, and racial and ethnic minorities bear a disproportionate financial burden, which worsens existing health disparities. In conclusion, addressing this crisis requires a comprehensive approach that emphasizes prevention, equitable access, value-based care, and the reduction of waste through streamlined administration and fair pricing. Sustainable strategies are essential to improve outcomes, contain costs, and narrow disparities as the prevalence of cardiovascular disease continues to rise.